Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455890) titled 'Alpha Lipoic Acid Plus Coenzyme Q10 Versus Coenzyme Q10 Alone in Asthenozoospermia' on March 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Mst.Sumyara Khatun

Condition: Asthenozoospermia

Intervention: Combination Product: ALA 500mg once daily for 3 month

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 1, 2024

Target Sample Size: 40

Countries of Recruitment: Bangladesh

To know more, visit https://clinicaltrials.gov/study/NCT07455890

Publi...